Ethinyloestradiol / Drospirenone 20 microgram/3 mg Lupin ethinylestradiol/drospirenone 20 microgram/3 mg tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

drospirenone, Quantity: 3 mg; ethinylestradiol, Quantity: 20 microgram

Disponibbli minn:

Lupin Australia Pty Limited

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: pregelatinised maize starch; lactose monohydrate; magnesium stearate; maize starch; titanium dioxide; hypromellose; macrogol 400

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

2 x 28 tablets, 6 x 28 tablets, 3 x 28 tablets, 4 x 28 tablets, 1 x 28 tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Ethinylestradiol/ Drospirenone tablet is indicated for use as:,?an oral contraceptive.,?treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of Ethinylestradiol/ Drospirenone tablet for PMDD was not assessed beyond 3 cycles. Ethinylestradiol/ Drospirenone tablet has not been evaluated for treatment of PMS (premenstrual syndrome).

Sommarju tal-prodott:

Visual Identification: White to off-white round, biconvex film coated tablets, plain on both the sides.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2020-09-11